Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines -…

ir.novavax.com Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwards • Provides…

Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots

cnbc.com A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague,…

UPDATE 2-Novavax signs COVID-19 license deal with Sanofi, removes doubt about business viability

finance.yahoo.com Novavax on Friday erased doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with Sanofi for COVID-19 vaccines in exchange…

Novavax stock soars 40% on Sanofi partnership

investing.com Novavax (NASDAQ: ) shares rocketed 40% in premarket trading Friday, driven by the company’s fiscal Q1 2024 report and more importantly, a vital, multi-billion dollar deal…

Novavax signs COVID-19 license deal with Sanofi, removes doubt about business viability

aol.com Novavax on Friday erased doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with Sanofi for COVID-19 vaccines in exchange…

Novavax erases doubts about its ability to remain in business

aol.com May 10, 2024 at 2:39 AM (Reuters) - COVID-19 vaccine maker Novavax, on Friday, erased doubts about its ability to remain in business by removing a so-called "going concern"…

AstraZeneca's COVID Vaccine Withdrawn

sciencealert.com The Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. However, on May 7 2024, the European Commission announced the vaccine is no longer…

Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts

finance.yahoo.com Since the page turned to 2023 a little over 16 months ago, the bulls have been running wild on Wall Street. Professional and everyday investors have flocked to high-growth,…

Novavax's top shareholder Shah Capital ramps up efforts for board shakeup

aol.com Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the re-election of three directors and proposals related to executive compensation, ramping up…

3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole

finance.yahoo.com The market isn't rational always and everywhere. Sometimes, shares of excellent companies with bright futures almost inexplicably fail to keep pace with broader equities.…